Luca Ielasi

Ospedale per gli Infermi — Italy

Medicine · Health Sciences

12h-index619citations55works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(40), Cancer, Lipids, and Metabolism(15), Colorectal Cancer Treatments and Studies(13), Liver Disease Diagnosis and Treatment(8), Lung Cancer Treatments and Mutations(7)

Publications55 total

Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study
Hepatology·2026
Etiology of hepatocellular carcinoma may influence the pattern of progression under atezolizumab-bevacizumab.
Liver Cancer·2025· 2 citedOpen Access
FRI-117 Impact of sarcopenia on medium-long-term survival of patients with hepatocellular carcinoma treated with lenvatinib
Journal of Hepatology·2025
FRI-116 The changing epidemiology of patients with HCC receiving a firstline systemic therapy: insights from ARPES and ARTE databases (2008–2024)
Journal of Hepatology·2025
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma
Digestive and Liver Disease·2024· 5 citedOpen Access
Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications
Gastroenterology Insights·2024· 2 citedOpen Access
Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib
Gastroenterology Insights·2024Open Access
THU-472-YI Sorafenib as a second-line treatment after failure of Atezolizumab/Bevacizumab
Journal of Hepatology·2024
SAT-477-YI The impact of etiologyon patterns of progression of advanced HCC
Journal of Hepatology·2024
Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
Journal of Liver Cancer·2024· 7 citedOpen Access
Comparative analysis of subclassification models in patients with intermediate stage hepatocellular carcinoma (BCLC B) receiving systemic therapy
Digestive and Liver Disease·2024
Aetiology of hepatocellular carcinoma and response to immunotherapy: is the problem inherent in the classification of non-viral disease?
Digestive and Liver Disease·2024
Prevention of hepatitis B reactivation in patients with hematologic malignancies treated with novel systemic therapies: Who and Why?
World Journal of Gastroenterology·2024· 2 citedOpen Access
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy
Current Oncology·2024· 21 citedOpen Access
Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art
World Journal of Gastroenterology·2023· 14 citedOpen Access
Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia
World Journal of Hepatology·2023· 8 citedOpen Access
Supplementary Data from Association of <i>NOS3</i> and <i>ANGPT2</i> Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2023Open Access
Data from Association of <i>NOS3</i> and <i>ANGPT2</i> Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2023Open Access
Data from Association of <i>NOS3</i> and <i>ANGPT2</i> Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2023Open Access
Supplementary Data from Association of <i>NOS3</i> and <i>ANGPT2</i> Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Francesco Tovoli(29), Fabio Piscaglia(28), Alessandro Granito(25), Andrea Casadei‐Gardini(18), Sara Lonardi(17), Caterina Vivaldi(16), Francesco Giuseppe Foschi(13), Stefano Cascinu(13), Bernardo Stefanini(12), Vito Sansone(12), Tiziana Pressiani(12), Mario Domenico Rizzato(12), Giorgia Marisi(11), Mario Scartozzi(11), Giulia Rovesti(10), Giulia Orsi(10), Rodolfo Sacco(10), Vincenzo Dadduzio(10), Laura Gramantieri(10), Giulia Magini(9)